Patents by Inventor Douglas H. Thamm

Douglas H. Thamm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lanthanide Nanoparticle Conjugates and Uses Thereof
    Publication number: 20150306256
    Abstract: The present disclosure is directed generally to lanthanide nanoparticle conjugates, such as gadolinium nanoparticle conjugates, nanoparticle conjugates including polymers, conjugation to targeting agents and therapeutic agents, and their use in targeting, treating, and/or imaging disease states in a patient.
    Type: Application
    Filed: December 23, 2014
    Publication date: October 29, 2015
    Inventors: Stephen G. Boyes, Misty D. Rowe, Douglas H. Thamm, Susan L. Kraft
  • Lanthanide nanoparticle conjugates and uses thereof
    Patent number: 8916135
    Abstract: The present disclosure is directed generally to lanthanide nanoparticle conjugates, such as gadolinium nanoparticle conjugates, nanoparticle conjugates including polymers, conjugation to targeting agents and therapeutic agents, and their use in targeting, treating, and/or imaging disease states in a patient.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: December 23, 2014
    Assignees: Colorado School of Mines, Colorado State University Research Foundation
    Inventors: Stephen G. Boyes, Misty D. Rowe, Douglas H. Thamm, Susan L. Kraft
  • Method for diagnosing hemangiosarcoma in canine using detection of thymidine kinase activity
    Patent number: 8354244
    Abstract: The disclosure relates to a method for detecting hemangiosarcoma in canines. The method includes the steps of: (1) obtaining a quantity of blood from the subject canine; (2) separating the quantity of blood into a serum portion and a non-serum portion; (3) contacting the serum portion of the blood with a detector to detect presence of an amount of Thymidine Kinase (TK); and (4) detecting the level of TK in serum and determining whether TK is present in amounts of about 8 units/L or greater.
    Type: Grant
    Filed: December 12, 2011
    Date of Patent: January 15, 2013
    Inventors: Randy Ringold, Renee Parker, Douglas H Thamm
  • METHOD FOR DIAGNOSING HEMANGIOSARCOMA IN CANINE USING DETECTION OF THYMIDINE KINASE ACTIVITY
    Publication number: 20120156690
    Abstract: The disclosure relates to a method for detecting hemangiosarcoma in canines. The method includes the steps of: (1) obtaining a quantity of blood from the subject canine; (2) separating the quantity of blood into a serum portion and a non-serum portion; (3) contacting the serum portion of the blood with a detector to detect presence of an amount of Thymidine Kinase (TK); and (4) detecting the level of TK in serum and determining whether TK is present in amounts of about 8 units/L or greater.
    Type: Application
    Filed: December 12, 2011
    Publication date: June 21, 2012
    Inventors: Randy Ringold, Renee Parker, Douglas H. Thamm
  • Method for diagnosing hemangiosarcoma in canine using detection of thymidine kinase activity
    Patent number: 8097432
    Abstract: The disclosure relates to a method for detecting hemangiosarcoma in canines. The method includes the steps of: (1) obtaining a quantity of blood from the subject canine; (2) separating the quantity of blood into a serum portion and a non-serum portion; (3) contacting the serum portion of the blood with a detector to detect presence of an amount of Thymidine Kinase (TK); and (4) detecting the level of TK in serum and determining whether TK is present in amounts of about 8 units/mL or greater.
    Type: Grant
    Filed: October 29, 2008
    Date of Patent: January 17, 2012
    Assignees: Veterinary Diagnostics Institute, Inc., Colorado State University Research Foundation
    Inventors: Randy Ringold, Renee Parker, Douglas H. Thamm
  • METHOD AND APPARATUS FOR DIAGNOSES OF HEMANGIOSARCOMA IN MAMMALS
    Publication number: 20090111135
    Abstract: The disclosure relates to a method for detecting hemangiosarcoma in canines. The method includes the steps of: (1) obtaining a quantity of blood from the subject canine; (2) separating the quantity of blood into a serum portion and a non-serum portion; (3) contacting the serum portion of the blood with a detector to detect presence of an amount of Thymidine Kinase (TK); and (4) detecting the level of TK in serum and determining whether TK is present in amounts of about 8 units/mL or greater.
    Type: Application
    Filed: October 29, 2008
    Publication date: April 30, 2009
    Applicant: VETERINARY DIAGNOSTICS INSTITUTE, INC.
    Inventors: Randy Ringold, Renee Parker, Douglas H. Thamm
  • Lanthanide Nanoparticle Conjugates and Uses Thereof
    Publication number: 20090060840
    Abstract: The present disclosure is directed generally to lanthanide nanoparticle conjugates, such as gadolinium nanoparticle conjugates, nanoparticle conjugates including polymers, conjugation to targeting agents and therapeutic agents, and their use in targeting, treating, and/or imaging disease states in a patient.
    Type: Application
    Filed: August 22, 2008
    Publication date: March 5, 2009
    Inventors: Stephen G. Boyes, Misty D. Rowe, Douglas H. Thamm, Susan L. Kraft